Germinal peptide eye drops

DRUG2 trials

Sponsors

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Conditions

Corneal Defect

Phase 1

Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

CompletedNCT03662971

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Corneal Defect

Start: 2018-10-29End: 2019-10-24Updated: 2020-02-05

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

CompletedNCT03967548

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Corneal Defect

Start: 2021-04-09End: 2021-06-15Updated: 2021-09-17